Abstract
In recent years, nanozyme-based catalytic therapy for tumors has garnered extensive attention. They combine the properties of nanomaterials and enzymes, precisely mimicking the structure of natural enzymes and exhibiting highly efficient catalytic ability. While nanozymes exert favorable catalytic therapeutic effects in the treatment of most tumors, their application in gliomas is limited by the unique physiological environment and the blood-brain barrier. In this study, a calcium atom nanozyme (CaCN) with peroxidase-like (POD-like) properties was developed. It can induce multiple cell death mechanisms in glioma cells, such as calcium overload and ferroptosis, and synergistically modulate the immune microenvironment. After being functionalized with transferrin (TF) targeting ligands and polyethylene glycol (PEG), it selectively crosses the blood-brain barrier, thereby inhibiting the malignant progression of glioma. © The Author(s) 2025.
| Original language | English |
|---|---|
| Article number | 716 |
| Number of pages | 19 |
| Journal | Journal of Nanobiotechnology |
| Volume | 23 |
| Online published | 13 Nov 2025 |
| DOIs | |
| Publication status | Published - 2025 |
Funding
The research was supported by the National Natural Science Foundation of China (No. 82072794) and National Natural Science Foundation of China (No. 82104838).
Research Keywords
- Single-atom nanozyme
- Glioblastoma therapy
- Ferroptosis
- Pyroptosis
- Immune reprogramming
Publisher's Copyright Statement
- This full text is made available under CC-BY-NC-ND 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/
Fingerprint
Dive into the research topics of 'Single-atom Ca nanozyme induces glioma death through Ca2+-overload-enhanced catalytic tumor nanotherapy, ferroptosis and synergistic remodeling of the immune microenvironment'. Together they form a unique fingerprint.Research output
- 2 Scopus Citations
- 1 Erratum
-
Correction: Single-atom Ca nanozyme induces glioma death through Ca2+-overload-enhanced catalytic tumor nanotherapy, ferroptosis and synergistic remodeling of the immune microenvironment
Jin, Z. (Co-first Author), Li, X. (Co-first Author), Hou, X. (Co-first Author), Hu, J., Zhuo, Y., Shi, J., Xu, T., Zhao, Q. & Jing, Z., Dec 2026, In: Journal of Nanobiotechnology. 24, 1, 7 p., 205.Research output: Journal Publications and Reviews › Erratum
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver